BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11079789)

  • 21. [The mismatch-repair genes and colon cancer].
    Moisio AL; Peltomäki P
    Duodecim; 1996; 112(4):337-40. PubMed ID: 10590651
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetic counseling in hereditary nonpolyposis colorectal cancer: an extended family with MSH2 mutation.
    Lynch HT; Lemon S; Smyrk T; Franklin B; Karr B; Lynch J; Slominski-Caster S; Murphy P; Connolly C
    Am J Gastroenterol; 1996 Dec; 91(12):2489-93. PubMed ID: 8946971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surgery of hereditary colorectal carcinoma].
    Pistorius S; Schackert HK; Nagel M; Saeger HD
    Zentralbl Chir; 2000; 125 Suppl 1():23-7. PubMed ID: 10929642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic testing by cancer site: colon (nonpolyposis syndromes).
    Senter L
    Cancer J; 2012; 18(4):334-7. PubMed ID: 22846734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal cancer: predicting prognosis for patients and probands using immunohistochemistry.
    Khurana V; Stollman N; Rogers AI
    Am J Gastroenterol; 2000 Oct; 95(10):2981-2. PubMed ID: 11051382
    [No Abstract]   [Full Text] [Related]  

  • 26. Critical issues in the identification and management of patients with hereditary non-polyposis colorectal cancer.
    Lackner C; Hoefler G
    Eur J Gastroenterol Hepatol; 2005 Mar; 17(3):317-22. PubMed ID: 15716656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures.
    Wagner A; van Kessel I; Kriege MG; Tops CM; Wijnen JT; Vasen HF; van der Meer CA; van Oostrom II; Meijers-Heijboer H
    Fam Cancer; 2005; 4(4):295-300. PubMed ID: 16341806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemistry to detect hereditary nonpolyposis colorectal cancer in young patients: the 7-year Auckland experience.
    Wright DM; Arnold JL; Parry B; Hulme-Moir M; Winship IM; Parry S
    Dis Colon Rectum; 2011 May; 54(5):552-8. PubMed ID: 21471755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical implications of molecular diagnosis in hereditary nonpolyposis colorectal cancer.
    Möslein G
    Recent Results Cancer Res; 2003; 162():73-8. PubMed ID: 12790322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mismatch repair protein].
    Ikejima M; Shimada T
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1392-400. PubMed ID: 9309131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiologic and genetic factor in colorectal cancer: development of cancer in dizygotic twins in a family with Lynch syndrome.
    Ponz de Leon M; Pedroni M; Benatti P; Percesepe A; Rossi G; Genuardi M; Roncucci L
    Ital J Gastroenterol Hepatol; 1999 Apr; 31(3):218-22. PubMed ID: 10379484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations.
    Syngal S; Weeks JC; Schrag D; Garber JE; Kuntz KM
    Ann Intern Med; 1998 Nov; 129(10):787-96. PubMed ID: 9841584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families.
    de Vos tot Nederveen Cappel WH; Nagengast FM; Griffioen G; Menko FH; Taal BG; Kleibeuker JH; Vasen HF
    Dis Colon Rectum; 2002 Dec; 45(12):1588-94. PubMed ID: 12473880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic colectomy for gene carriers in hereditary nonpolyposis colorectal cancer. Has the time come?
    Rodríguez-Bigas MA
    Cancer; 1996 Jul; 78(2):199-201. PubMed ID: 8673992
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC.
    Di Fiore F; Charbonnier F; Martin C; Frerot S; Olschwang S; Wang Q; Boisson C; Buisine MP; Nilbert M; Lindblom A; Frebourg T
    J Med Genet; 2004 Jan; 41(1):18-20. PubMed ID: 14729822
    [No Abstract]   [Full Text] [Related]  

  • 36. Cancer risk in mutation carriers of DNA-mismatch-repair genes.
    Aarnio M; Sankila R; Pukkala E; Salovaara R; Aaltonen LA; de la Chapelle A; Peltomäki P; Mecklin JP; Järvinen HJ
    Int J Cancer; 1999 Apr; 81(2):214-8. PubMed ID: 10188721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer?
    Vasen HF; Morreau H; Nortier JW
    Am J Hum Genet; 2001 Jun; 68(6):1533-5. PubMed ID: 11359214
    [No Abstract]   [Full Text] [Related]  

  • 38. DNA mismatch repair and cancer.
    Peltomäki P
    Mutat Res; 2001 Mar; 488(1):77-85. PubMed ID: 11223406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care survey.
    Barrow P; Green K; Clancy T; Lalloo F; Hill J; Evans DG
    Clin Genet; 2015 Jun; 87(6):517-24. PubMed ID: 25652327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary non-polyposis colorectal cancer: identification of mutation carriers and assessing pathogenicity of mutations.
    Niessen RC; Sijmons RH; Berends MJ; Ou J; Hofstra RM; Kleibeuker JH
    Scand J Gastroenterol Suppl; 2004; (241):70-7. PubMed ID: 15696853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.